Skip to main content
. 2015 Oct 2;10(10):e0139049. doi: 10.1371/journal.pone.0139049

Table 3. Deviations between the assays at specific cutoffs.

Cancer Patients Control Subjects
Assay 2 Assay 2
37 U/mL Low High 37 U/mL Low High
Assay 1 Low 38 7 Assay 1 Low 121 7
  High 8 45   High 9 17
Cancer Patients Control Subjects
Assay 2 Assay 2
100 U/mL Low High 100 U/mL Low High
Assay 1 Low 68 2 Assay 1 Low 139 5
  High 4 24   High 4 6